| |
|
|
|
VBI Vaccines Inc.  
|
|
1.98 0.01 (0.01%) |
04-22 16:00 |
|
Open: |
1.98 |
Pre close: |
1.97 |
Target:
|
2.57
|
|
High: |
2 |
Low: |
1.895 |
Resistance:
|
2.20
2.57
|
|
Volume: |
161,861 |
Market Cap: |
193M |
Support:
|
1.91
1.73
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.04
 |
MACD |
MACD(12,26):
|
0.04 |
|
MA(20): |
1.97  |
Signal(12,26,9): |
0.04 |
|
MA(100): |
1.76 |
Stochastic Oscillator |
%K(14,3):
|
56.04 |
|
MA(250): |
2.18 |
%D(3): |
64.60 |
|
Average Volume(K) |
3-Month: |
32600
|
52-Week |
High:
|
3.95 |
|
10-Days: |
37999 |
Low: |
1.14 |
|
RSI |
RSI(14):
|
50.43 |
Change(%): |
-38.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-59.8 |
Shares Out. (M) |
64.08 |
|
EPS Est. Current Year |
-0.890 |
Return on Assets (ttm) |
-45.9 |
Shares Float (M) |
62.84 |
|
EPS Est. Next Year |
-1.010 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
1235.3 |
% Held by Institutions |
65.70 |
|
Forward EPS |
-0.971 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.990 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.99 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-45.53 |
P/S |
3867335936.00 |
|
Operating Margin |
-1792.25 |
Levered Free Cash Flow
(M) |
-29.57 |
P/CF |
-2.79 |
|
|
|
|
|
|
